Market Overview

Acacia Subsidiary Enters into Settlement Agreement with AstraZeneca

Related ACTG
Market Wrap for Friday, July 25: Earnings Misses Take Equities Lower
Amazon Rating And Price Target Cut; Pandora Reports Slow Growth

Acacia Research Corporation (NASDAQ: ACTG) announced today that its
Accuhale LLC subsidiary has entered into a settlement agreement
regarding pressurized metered dose inhalers with AstraZeneca LP (NYSE: AZN),
AstraZeneca Pharmaceuticals LP, AstraZeneca Dunkerque Production SCS and
AstraZeneca AB. The agreement resolves litigation that was pending in
the United States District Court for the Eastern District of Texas.

See full press release

Posted-In: News Guidance Contracts Asset Sales Legal Management Global

 

Most Popular

Related Articles (ACTG + AZN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters